Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
PK Judge, Natalie Staplin, KJ Mayne, Christoph Wanner et autres
in, gb, de, us (code pays fourni par la source)
121 citations
The Lancet Diabetes & Endocrinology